翔宇医疗(688626.SH)：目前主要聚焦非侵入式脑机接口技术 截至2025年末尚未实现规模化销售

Core Viewpoint - The company, Xiangyu Medical, has noted increased market attention on brain engineering and brain-machine interface concepts, leading to significant stock price increases in related sectors [1] Company Focus - The company primarily focuses on non-invasive brain-machine interface technology, which encompasses a comprehensive rehabilitation layout including occupational therapy, motor therapy, cognitive speech, and swallowing [1] - This approach differs from the current international trend towards invasive brain-machine interface technologies [1] Market Position and Development - The company has made investments in brain-machine interface technology, establishing a certain level of layout in technology, products, and market channels [1] - However, the company faces delays in bidding and sales processes, with related products not expected to achieve large-scale sales until the end of 2025, resulting in a small revenue contribution [1]